WO2004009636A3 - Gnrh modulator - Google Patents

Gnrh modulator Download PDF

Info

Publication number
WO2004009636A3
WO2004009636A3 PCT/GB2003/003314 GB0303314W WO2004009636A3 WO 2004009636 A3 WO2004009636 A3 WO 2004009636A3 GB 0303314 W GB0303314 W GB 0303314W WO 2004009636 A3 WO2004009636 A3 WO 2004009636A3
Authority
WO
WIPO (PCT)
Prior art keywords
gnrh
amino acid
acid sequence
receptor
type
Prior art date
Application number
PCT/GB2003/003314
Other languages
French (fr)
Other versions
WO2004009636A2 (en
Inventor
Robert Peter Millar
Adam James Pawson
Original Assignee
Ardana Bioscience Ltd
Robert Peter Millar
Adam James Pawson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216939A external-priority patent/GB0216939D0/en
Priority claimed from GB0222541A external-priority patent/GB0222541D0/en
Application filed by Ardana Bioscience Ltd, Robert Peter Millar, Adam James Pawson filed Critical Ardana Bioscience Ltd
Priority to AU2003269087A priority Critical patent/AU2003269087A1/en
Publication of WO2004009636A2 publication Critical patent/WO2004009636A2/en
Publication of WO2004009636A3 publication Critical patent/WO2004009636A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A GnRH Type II hemi-receptor having an amino acid sequence as shown in Figure (2A), or having substantially the amino acid sequence shown in Figure (2A), or functional equivalents thereof. A GnRH Type II hemi-receptor having an amino acid sequence as shown in Figure (2B), or having substantially the amino acid sequence shown in Figure (2B), or functional equivalents thereof. The GnRH Type II hemi-receptor may be used for modulating Type I GnRH receptor activity, for inhibiting the growth of hormone dependent tumours, or for treating sexual dysfunction in an individual.
PCT/GB2003/003314 2002-07-22 2003-07-22 Gnrh modulator WO2004009636A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003269087A AU2003269087A1 (en) 2002-07-22 2003-07-22 Gnrh modulator

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0216939A GB0216939D0 (en) 2002-07-22 2002-07-22 Novel GnRH modulator
GB0216939.9 2002-07-22
GB0222541A GB0222541D0 (en) 2002-09-28 2002-09-28 "Novel GnRH modulator"
GB0222541.5 2002-09-28

Publications (2)

Publication Number Publication Date
WO2004009636A2 WO2004009636A2 (en) 2004-01-29
WO2004009636A3 true WO2004009636A3 (en) 2004-04-15

Family

ID=30772043

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/003314 WO2004009636A2 (en) 2002-07-22 2003-07-22 Gnrh modulator

Country Status (2)

Country Link
AU (1) AU2003269087A1 (en)
WO (1) WO2004009636A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047743A1 (en) * 1996-06-13 1997-12-18 Zymogenetics, Inc. Human type ii gonadotropin-releasing hormone receptor
WO2001078796A1 (en) * 2000-04-15 2001-10-25 Medical Res Council Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047743A1 (en) * 1996-06-13 1997-12-18 Zymogenetics, Inc. Human type ii gonadotropin-releasing hormone receptor
WO2001078796A1 (en) * 2000-04-15 2001-10-25 Medical Res Council Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEILL J D: "Minireview: GnRH and GnRH receptor genes in the human genome", ENDOCRINOLOGY, BALTIMORE, MD, US, vol. 143, no. 3, March 2002 (2002-03-01), pages 737 - 743, XP002264358, ISSN: 0013-7227 *

Also Published As

Publication number Publication date
AU2003269087A1 (en) 2004-02-09
AU2003269087A8 (en) 2004-02-09
WO2004009636A2 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
EP1190099A4 (en) Antisense modulation of pi3k p85 expression
WO2003023005A3 (en) Antisense modulation of pka regulatory subunit rii alpha expression
WO2006048777A3 (en) Modified growth hormones
WO2001079461A3 (en) Polypeptides having haloperoxidase activity
WO2003053340A3 (en) Antisense modulation of connective tissue growth factor expression
WO2003061584A3 (en) Novel substituted benzimidazole dosage forms and method of using same
WO2002036743A3 (en) Antisense modulation of calreticulin expression
WO2003014307A3 (en) Antisense modulation of apolipoprotein(a) expression
HK1048050A1 (en) Pharmaceutical composition for muscular anabolism
WO2003052072A3 (en) Antisense modulation of estrogen receptor alpha expression
WO2003010284A3 (en) Antisense modulation of c-reactive protein expression
WO2003046132A3 (en) Antisense modulation of myd88 expression
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
WO2003053341A3 (en) Antisense modulation of ship-1 expression
WO2002095053A3 (en) Antisense modulation of src-c expression
WO2006031607A3 (en) A method of treating cancer
WO2001031051A3 (en) Antisense modulation of protein kinase c-theta expression
EP1165145A4 (en) Antisense modulation of mdmx expression
WO2003050244A3 (en) Antisense modulation of g protein-coupled receptor etbr-lp-2 expression
WO2003052062A3 (en) Antisense modulation of cd36l1 expression
WO2004009636A3 (en) Gnrh modulator
EP1506216A4 (en) Antisense moodulation of kinesin-like 1 expression
WO2004003152A3 (en) Sos1 inhibitors
EP1390388A4 (en) Antisense modulation of interferon gamma receptor 1 expression
WO2004003201A3 (en) Antisense modulation of lrh1 expression

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP